110 related articles for article (PubMed ID: 21778315)
21. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.
Kanth VR; Lavanya K; Srinivas J; Raju TN
Curr Eye Res; 2009 Apr; 34(4):274-81. PubMed ID: 19373575
[TBL] [Abstract][Full Text] [Related]
22. Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity.
Maes M; Galecki P; Verkerk R; Rief W
Neuro Endocrinol Lett; 2011; 32(3):264-73. PubMed ID: 21712776
[TBL] [Abstract][Full Text] [Related]
23. Malaria parasite induces tryptophan-related immune suppression in mice.
Tetsutani K; To H; Torii M; Hisaeda H; Himeno K
Parasitology; 2007 Jul; 134(Pt 7):923-30. PubMed ID: 17316473
[TBL] [Abstract][Full Text] [Related]
24. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
Orabona C; Grohmann U
Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
26. Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation.
Brandacher G; Margreiter R; Fuchs D
Curr Opin Organ Transplant; 2008 Feb; 13(1):10-5. PubMed ID: 18660700
[TBL] [Abstract][Full Text] [Related]
27. Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia.
Pschowski R; Pape UF; Fusch G; Fischer C; Jann H; Baur A; Arsenic R; Wiedenmann B; von Haehling S; Pavel M; Schefold JC
Neuroendocrinology; 2017; 104(2):135-144. PubMed ID: 26954941
[TBL] [Abstract][Full Text] [Related]
28. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients.
Huttunen R; Syrjänen J; Aittoniemi J; Oja SS; Raitala A; Laine J; Pertovaara M; Vuento R; Huhtala H; Hurme M
Shock; 2010 Feb; 33(2):149-54. PubMed ID: 19487973
[TBL] [Abstract][Full Text] [Related]
29. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.
Cozzi A; Zignego AL; Carpendo R; Biagiotti T; Aldinucci A; Monti M; Giannini C; Rosselli M; Laffi G; Moroni F
J Viral Hepat; 2006 Jun; 13(6):402-8. PubMed ID: 16842443
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms.
Raitala A; Karjalainen J; Oja SS; Kosunen TU; Hurme M
Mol Immunol; 2007 Feb; 44(5):1011-4. PubMed ID: 16620985
[TBL] [Abstract][Full Text] [Related]
31. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
[TBL] [Abstract][Full Text] [Related]
32. Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers.
Sperner-Unterweger B; Neurauter G; Klieber M; Kurz K; Meraner V; Zeimet A; Fuchs D
Immunobiology; 2011 Mar; 216(3):296-301. PubMed ID: 20822828
[TBL] [Abstract][Full Text] [Related]
33. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy.
Raitala A; Karjalainen J; Oja SS; Kosunen TU; Hurme M
Mol Immunol; 2006 Mar; 43(7):1054-6. PubMed ID: 15992929
[TBL] [Abstract][Full Text] [Related]
34. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
[TBL] [Abstract][Full Text] [Related]
35. Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma.
Pellegrin K; Neurauter G; Wirleitner B; Fleming AW; Peterson VM; Fuchs D
Shock; 2005 Mar; 23(3):209-15. PubMed ID: 15718917
[TBL] [Abstract][Full Text] [Related]
36. Increased tryptophan degradation in patients with bronchus carcinoma.
Engin AB; Ozkan Y; Fuchs D; Yardim-Akaydin S
Eur J Cancer Care (Engl); 2010 Nov; 19(6):803-8. PubMed ID: 19702697
[TBL] [Abstract][Full Text] [Related]
37. Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model.
Källberg E; Wikström P; Bergh A; Ivars F; Leanderson T
Prostate; 2010 Sep; 70(13):1461-70. PubMed ID: 20687219
[TBL] [Abstract][Full Text] [Related]
38. High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.
Habibi D; Jalili RB; Forouzandeh F; Ong CJ; Ghahary A
J Cell Physiol; 2010 Oct; 225(1):196-205. PubMed ID: 20648630
[TBL] [Abstract][Full Text] [Related]
39. In vitro modulation of cytochrome P450 reductase supported indoleamine 2,3-dioxygenase activity by allosteric effectors cytochrome b(5) and methylene blue.
Pearson JT; Siu S; Meininger DP; Wienkers LC; Rock DA
Biochemistry; 2010 Mar; 49(12):2647-56. PubMed ID: 20178337
[TBL] [Abstract][Full Text] [Related]
40. High expression of indoleamine 2,3-dioxygenase gene in prostate cancer.
Feder-Mengus C; Wyler S; Hudolin T; Ruszat R; Bubendorf L; Chiarugi A; Pittelli M; Weber WP; Bachmann A; Gasser TC; Sulser T; Heberer M; Spagnoli GC; Provenzano M
Eur J Cancer; 2008 Oct; 44(15):2266-75. PubMed ID: 18619832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
